2018 AANS Annual Scientific Meeting-550. Clinical Outcomes in a Large Series of Subtemporal Selective Amygdalohippocampectomies for Medically Refractory Epilepsy

550. Clinical Outcomes in a Large Series of Subtemporal Selective Amygdalohippocampectomies for Medically Refractory Epilepsy

Back to course

Video Transcription

Video Summary

In a video presentation, Dr. Shinsu Chen from the Barrow Neurological Institute discussed the clinical outcomes of 152 patients who underwent a sub-temporal selective approach for the treatment of medically refractory epilepsy. The study found that 58% of patients achieved ENGL class one outcome at one year, and this remained steady at 56.5% at two years. The study also demonstrated a low morbidity and mortality rate, with 1.3% experiencing permanent neurological deficits and no reported fatalities. However, there were limitations to the study, including its retrospective design and lack of a comparison group. Dr. Chen also discussed the debate surrounding the use of laser ablation as a minimally invasive alternative to the selective approach.

Asset Caption

Tsinsue Chen, MD

Keywords

clinical outcomes

epilepsy treatment

selective approach

morbidity rate

laser ablation